New therapies pack a triple-drug punch to treat cystic fibrosis
The approach, still in clinical trials, might one day provide relief to many with the disease
TO BREATHE EASIER In clinical trials, two triple-drug therapies improved lung function for cystic fibrosis patients who have the most common disease-causing mutation.
Zakharishchev/Shutterstock
This article is only available to Science News subscribers.
Subscribers, enter your e-mail address to access our archives.
